Preise Hobisch

Univ. Doz. Prim. Dr. A. Hobisch
Preise
10.1993
1. Posterpreis der Deutschen Gesellschaft für Urologie (DGU)
„Androgenrezeptormutation
in
einem
fortgeschrittenen
Prostatakarzinom: Charakterisierung des Rezeptors“
12.1993
Award of the Society for Basic Urological Research (SBUR) in
recognition of the outstanding abstract „Mutant androgen receptor
detected in an advanced stage prostatic carcinoma is activated by
adrenal androgens and progesterone“
10.1993
Smith Kline Beecham Ecucational Grant of the European Society for
Urological Oncology and Endocrinology (ESUOE)
„Products of Dihydrotestosterone Metabolism Activate a Mutant
Androgen Receptor Detected in a Late Stage Prostatic Carcinoma“
10.1993
Grosshaderner Innovationspreis
„Androgen Receptor Alterations in Patients with Disturbances of Male
Sexual Development and in Prostatic Carcinoma“
11.1994
Heinrich Warner Preis für die Jahre 1993/94
„Activation of the Androgen Receptor in Prostatic Cancer Cells by
Insulin Like Growth Factor I, Keratinocyte Growth Factor and Epidermal
Growth Factor“
06.1995
Smith Kline Beecham Educational Grant of the European Society
for Urological Oncology and Endocrinology (ESUOE) and the
Society for Basic Urological Research (SBUR)
„Induction of Androgen-receptor Mediated Gene Transcription in
Response to Luteinizing Hormone Releasing Hormone“
04.1996
Posterpreis der American Association of Cancer Research (AACR)
„Dendritic Cells from the Peripheral Blood for the Active Immunotherapy
of Renal Cell Carcinoma“
01.1997
Reinhold – Witzel – Preis 1996
„Distant Metastases from Prostatic Carcinoma Express Androgen
Receptor Protein“
03.1997
Preis vergeben von der Association pour la Recherche sur les
Tumeurs de la Prostate (ARTP)
„Androgen Receptor Deletion Mutants in the Cross-talk between
Androgen and Polypeptide Signaling Pathways“
03.1998
National Institue of Health (NIH) Posterpreis
„Agonistic Action of Bicalutamide (Casodex) in a New LNCaP Subline
Obtained after Long-term Androgen Ablation“
05.1998
Günther E. Voges Preis der Bayerischen Urologenvereinigung und
der Östrreichischen Gesellschaft für Urologie
„Androgenlangzeitablation in LNCaP Zellen führt zur Steigerung der
Androgenrezeptoraktivität und Verlust der Transforming Wachstums
Faktor-ß Sensitivität“ und „Up-Regulation der AndrogenrezeptorAktivität durch Interleukin-6 in Prostatakarzinomzellen“
12.1998
CaP CURE Forschungspreis
„Function of Androgen Receptor Coactivators and Corepressors in
Advanced Carcinoma of the Prostate“
01.1999
Dr. Otto Seibert – Wissenschafts – Förderungs – Preis
„Synergistic Activation of Androgen Receptor by Androgen and
Luteinizing Hormone-Releasing Hormone in Prostatic Carcinoma Cells“
03.1999
Qualitätspreis der Tiroler Landeskrankenanstalten Ges.m.b.H.
(TILAK) für das ANTI-WARTE-PROGRAMM an der Universitätsklinik
für Urologie
04.1999
American Urological Association (AUA), Best Abstract, Prostate
Cancer Category
„Androgens, Protein Kinase A Activators, and Growth Factors use
Different Mechanisms to Activate the Androgen Receptor“
01.2000
Grosshaderner Innovationspreis 1999
„Wechsel zwischen antagonistischer und agonistischer Aktivität des
nichtsteroidalen Antiandrogens Bikalutamid (Casodex) in einem neuen
Prostatakarzinommodell“
04.2000
Society for Basic Urological Research/Merck (SBUR) Young
Investigator Preis
(wurde 25 x in den Vereinigten Staaten verliehen, erstmals an einen
Europäer)
04.2001
European Association for Urology (EAU) Best Posterprize in
Urological Oncology
„Alterations in androgen receptor activity and growth factor production
during intermittent androgen withdrawal in vitro“
04.2001
European Association for Urology (EAU) Best Video Prize
„Laparoscopic retroperitoneal lymph node dissection for testicular
cancer“
12.2001
Award of the Society for Basic Urological Research (SBUR/ESUR)
“Oncostatin M-iduced androgen receptor activation cannot be blocked
by antiandrogens in prostate cancer cells”
10.2002
Scientific Award – University of Iowa
“2nd international conference on prostate cancer research”
06.2003
CaPCure Research Award
Inhibition of expressin o fthe androgen-coactivator CBP in prostate
cancere in vivo
03.2007
EAU Best Paper Published in Urological Literature Award 2006
Suppressor of cytokine signaling-3 antgonizes cAMP effets on
proliferation and apoptosis and is expressed in human prostate cancer